| UniProt ID | LRFN4_HUMAN | |
|---|---|---|
| UniProt AC | Q6PJG9 | |
| Protein Name | Leucine-rich repeat and fibronectin type-III domain-containing protein 4 | |
| Gene Name | LRFN4 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 635 | |
| Subcellular Localization |
Membrane Single-pass type I membrane protein. |
|
| Protein Description | Promotes neurite outgrowth in hippocampal neurons. May play a role in redistributing DLG4 to the cell periphery (By similarity).. | |
| Protein Sequence | MAPPLLLLLLASGAAACPLPCVCQNLSESLSTLCAHRGLLFVPPNVDRRTVELRLADNFIQALGPPDFRNMTGLVDLTLSRNAITRIGARAFGDLESLRSLHLDGNRLVELGTGSLRGPVNLQHLILSGNQLGRIAPGAFDDFLESLEDLDLSYNNLRQVPWAGIGAMPALHTLNLDHNLIDALPPGAFAQLGQLSRLDLTSNRLATLAPDPLFSRGRDAEASPAPLVLSFSGNPLHCNCELLWLRRLARPDDLETCASPPGLAGRYFWAVPEGEFSCEPPLIARHTQRLWVLEGQRATLRCRALGDPAPTMHWVGPDDRLVGNSSRARAFPNGTLEIGVTGAGDAGGYTCIATNPAGEATARVELRVLALPHGGNSSAEGGRPGPSDIAASARTAAEGEGTLESEPAVQVTEVTATSGLVSWGPGRPADPVWMFQIQYNSSEDETLIYRIVPASSHHFLLKHLVPGADYDLCLLALSPAAGPSDLTATRLLGCAHFSTLPASPLCHALQAHVLGGTLTVAVGGVLVAALLVFTVALLVRGRGAGNGRLPLKLSHVQSQTNGGPSPTPKAHPPRSPPPRPQRSCSLDLGDAGCYGYARRLGGAWARRSHSVHGGLLGAGCRGVGGSAERLEESVV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 25 | N-linked_Glycosylation | PLPCVCQNLSESLST CHHHHHCCHHHHHHH | 40.17 | UniProtKB CARBOHYD | |
| 50 | Phosphorylation | PPNVDRRTVELRLAD CCCCCCCCEEEHHHH | 21.16 | 22210691 | |
| 70 | N-linked_Glycosylation | LGPPDFRNMTGLVDL HCCCCHHCCCCCEEE | 32.15 | UniProtKB CARBOHYD | |
| 78 | Phosphorylation | MTGLVDLTLSRNAIT CCCCEEEECCCCHHH | 20.44 | 24719451 | |
| 324 | N-linked_Glycosylation | PDDRLVGNSSRARAF CCCCCCCCCCCCEEC | 29.36 | UniProtKB CARBOHYD | |
| 333 | N-linked_Glycosylation | SRARAFPNGTLEIGV CCCEECCCCCEEEEC | 50.02 | UniProtKB CARBOHYD | |
| 376 | N-linked_Glycosylation | LALPHGGNSSAEGGR EECCCCCCCCCCCCC | 37.07 | UniProtKB CARBOHYD | |
| 377 | Phosphorylation | ALPHGGNSSAEGGRP ECCCCCCCCCCCCCC | 33.91 | 22210691 | |
| 378 | Phosphorylation | LPHGGNSSAEGGRPG CCCCCCCCCCCCCCC | 34.05 | 22210691 | |
| 440 | N-linked_Glycosylation | WMFQIQYNSSEDETL EEEEEEECCCCCCEE | 23.76 | UniProtKB CARBOHYD | |
| 558 | Phosphorylation | LKLSHVQSQTNGGPS EEEECEECCCCCCCC | 37.57 | 27732954 | |
| 560 | Phosphorylation | LSHVQSQTNGGPSPT EECEECCCCCCCCCC | 40.87 | 27732954 | |
| 565 | Phosphorylation | SQTNGGPSPTPKAHP CCCCCCCCCCCCCCC | 44.68 | 25159151 | |
| 567 | Phosphorylation | TNGGPSPTPKAHPPR CCCCCCCCCCCCCCC | 41.58 | 28387310 | |
| 575 | Phosphorylation | PKAHPPRSPPPRPQR CCCCCCCCCCCCCCC | 47.75 | 26329039 | |
| 583 | Phosphorylation | PPPRPQRSCSLDLGD CCCCCCCCCCCCCCC | 11.65 | 22617229 | |
| 585 | Phosphorylation | PRPQRSCSLDLGDAG CCCCCCCCCCCCCCH | 26.60 | 23401153 | |
| 594 | Phosphorylation | DLGDAGCYGYARRLG CCCCCHHHHHHHHHC | 16.56 | 22817900 | |
| 608 | Phosphorylation | GGAWARRSHSVHGGL CCCCCCCCCCCCCCC | 17.98 | 30576142 | |
| 610 | Phosphorylation | AWARRSHSVHGGLLG CCCCCCCCCCCCCCC | 19.63 | 23401153 | |
| 626 | Phosphorylation | GCRGVGGSAERLEES CCCCCCCCHHHHHHH | 22.49 | 23401153 | |
| 633 | Phosphorylation | SAERLEESVV----- CHHHHHHHCC----- | 20.85 | 23401153 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of LRFN4_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LRFN4_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LRFN4_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-626, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-626, AND MASSSPECTROMETRY. | |